Client News

Home/Client News
Client News 2018-08-28T11:24:45+00:00
December 4, 2017
Opiant Pharmaceuticals, Inc. Reports Fiscal First Quarter 2018 Financial Results
SANTA MONICA, Calif., Dec. 04, 2017 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. (“Opiant”) (OPNT), a specialty pharmaceutical company developing pharmacological treatments for addictions, today reported ...
December 4, 2017
First Patient Enrolled in Phase 3 Trial for ATIR101™ in Adult Patients with Blood Cancer
AMSTERDAM-DUIVENDRECHT, The Netherlands--(BUSINESS WIRE)--Regulatory News: Kiadis Pharma N.V. (“Kiadis Pharma” or the “Company”) (Euronext Amsterdam and Brussels: KDS), a clinical stage biopharmaceutical company developing innovative cell-therapy ...
December 4, 2017
Biophytis has FAMHP Approval to conduct SARA-INT phase 2b Interventional Study of Sarconeos in Sarcopenia in Belgium
PARIS, Dec. 04, 2017 (GLOBE NEWSWIRE) -- BIOPHYTIS (Euronext Growth Paris:ALBPS), a biotechnology company specializing in the development of drug candidates to treat age-related diseases, ...
December 4, 2017
AzurRx BioPharma to Present at the Biotech Showcase 2018 Conference (January 8th)
BROOKLYN, N.Y., Dec. 04, 2017 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (AZRX) (“AzurRx” or the “Company”), a company specializing in the development of non-systemic, recombinant ...
December 4, 2017
Zogenix Announces New Positive Efficacy and Safety Data from Pivotal Phase 3 Clinical Trial of ZX008 in Dravet Syndrome
EMERYVILLE, Calif., Dec. 04, 2017 (GLOBE NEWSWIRE) --  Zogenix, Inc. (ZGNX), a pharmaceutical company developing therapies for the treatment of rare central nervous system (CNS) ...
December 4, 2017
CymaBay Therapeutics Strengthens Management Team with Appointment of Paul Quinlan as General Counsel
NEWARK, Calif., Dec. 04, 2017 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (CBAY), a clinical-stage biopharmaceutical company focused on developing therapies for liver and other chronic ...
December 4, 2017
La Jolla Pharmaceutical Company Announces Initiation of Pivotal Clinical Study of LJPC‑401 in Patients with Beta Thalassemia
SAN DIEGO, Dec. 04, 2017 (GLOBE NEWSWIRE) -- La Jolla Pharmaceutical Company(LJPC) (the Company or La Jolla) today announced the initiation of a pivotal clinical ...
December 4, 2017
VALNEVA to Conduct Investor and Partnering Meetings during the Annual J.P. Morgan Healthcare Conference
Lyon (France), December 4, 2017 - Valneva SE today announces that its senior management team will hold investor and partnering meetings in San Francisco during ...
November 22, 2017
ABIVAX to Present at German Equity Forum 2017
ABIVAX (ABVX.PA) (Euronext Paris: FR0012333284 – ABVX), an innovative biotechnology company targeting the immune system to eliminate viral and inflammatory diseases, as well as cancer, ...
November 22, 2017
Gemphire to Present at the Piper Jaffray and LD Micro Investor Conferences
LIVONIA, Mich., Nov. 22, 2017 (GLOBE NEWSWIRE) -- Gemphire Therapeutics Inc. (GEMP), a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for cardiometabolic disorders, ...
November 22, 2017
Ignyta to Present at the 29th Annual Piper Jaffray Healthcare Conference
SAN DIEGO--(BUSINESS WIRE)--Ignyta, Inc. (RXDX), a biotechnology company focused on precision medicine in oncology, announced today that Jonathan Lim, M.D., its Chairman and Chief Executive Officer, ...
November 22, 2017
Prometic Reports Positive Interim Clinical Data from Ongoing Intravenous Immunoglobulin (IVIG) Pivotal Phase 3 Trial
LAVAL, QC , Nov. 22, 2017 /CNW Telbec/ - Prometic Life Sciences Inc. (PLI.TO) (PFSCF) (Prometic) today announced positive interim six-month clinical data from its ongoing ...
November 22, 2017
Soleno Therapeutics to Present at the Piper Jaffray 29th Annual Healthcare Conference
REDWOOD CITY, Calif., Nov. 22, 2017 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare ...
November 22, 2017
Innate Pharma provides an update on Lirilumab
Innate Pharma SA (the "Company" - Euronext Paris: FR0010331421 - IPH) today provides an update on the clinical study program of lirilumab, licensed to Bristol-Myers ...
November 21, 2017
Kamada Announces New Supply Agreement with International Organization for KamRAB for Post-Exposure Prophylaxis Against Rabies Infection
REHOVOT, Israel, Nov. 21, 2017 (GLOBE NEWSWIRE) -- Kamada Ltd. (KMDA) (KMDA), a plasma-derived protein therapeutics company focused on orphan indications, announced today that it ...
November 21, 2017
Palatin Technologies Announces Signing of Licensing Agreement with Kwangdong Pharmaceutical for Republic of Korea
CRANBURY, N.J., Nov. 21, 2017 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE MKT: PTN; "Palatin") announced today that it has entered into a collaboration and license agreement ...
November 21, 2017
New Data from Zogenix’s Phase 3 Trial of ZX008 in Dravet Syndrome (Study 1) and Findings on Disease Impact to be Presented at 71st American Epilepsy Society Annual Meeting
EMERYVILLE, Calif., Nov. 21, 2017 (GLOBE NEWSWIRE) -- Zogenix, Inc. (ZGNX), a pharmaceutical company developing therapies for the treatment of rare central nervous system (CNS) ...
November 21, 2017
VBL Therapeutics to Present at the Piper Jaffray 29th Annual Healthcare Conference
TEL AVIV, Israel, Nov. 21, 2017 (GLOBE NEWSWIRE) -- VBL Therapeutics (VBLT), a clinical-stage biotechnology company focused on the discovery, development and commercialization of first-in-class ...
November 21, 2017
Altimmune to Present at the 29th Annual Piper Jaffray Conference
GAITHERSBURG, Md., Nov. 21, 2017 (GLOBE NEWSWIRE) -- Altimmune, Inc. (ALT), a clinical-stage immunotherapeutics company, today announced that Bill Enright, president and chief executive officer ...
November 21, 2017
AIT Therapeutics to Hold Clinical Update Meeting on November 28, 2017 at 7:30 a.m.
NEW YORK, Nov. 21, 2017 (GLOBE NEWSWIRE) -- AIT Therapeutics Inc. (AITB), a clinical-stage biopharmaceutical company focused on developing inhaled Nitric Oxide (NO) for the ...
Page 120 of 162